# Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible

> **NCT01361334** · PHASE2 · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 20 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Pazopanib

## Key facts

- **NCT ID:** NCT01361334
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361334, "Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01361334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*